Literature DB >> 8557319

Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.

D Gowal1, A K Tahlan.   

Abstract

Efficacy of mouse brain inactivated Japanese encephalitis vaccine was evaluated by studying the immune status of volunteers 1,2,3,4.5 and 7.5 yr after immunization. Neutralizing (N) antibody which is protective and found to correlate with the immunity after vaccination was estimated in serum by plaque reduction neutralizing test on chick embryo cell monolayer. Mean N-antibody titres of 3.25 (pre-booster) and 3.6, 2.8, 2.06, 1.85 and 1.50 log10 were observed post-booster, and 1,2,3, and 4.5 yr of immunization in volunteers who received complete immunization (3 doses). All the volunteers retained more than 1.0 log10 titre of protective N-antibody in spite of the loss of 0.8, 0.74, 0.21 and 0.35 log10 after 1,2,3, and 4.5 yr respectively. Similarly mean N-antibody titres of 1.6, 3.25, 2.4, 2.25, 1.92 and 1.60 log10 were observed pre-booster, after a single booster dose, and 1,2,3 and 4.5 yr of vaccination in individuals who received only a single booster dose. Ten serum samples of volunteers tested after 7.5 yr of vaccination showed that those who were in constant contact with JE virus (n = 7) in the laboratory maintained high levels of N-antibody whereas others (n = 3) showed a fall in titre indicating the necessity of a booster dose.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557319

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  4 in total

1.  Viral encephalitis of public health significance in India: current status.

Authors:  R Kumar
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

Review 2.  Japanese Encephalitis Vaccines.

Authors:  Vijaya Satchidanandam
Journal:  Curr Treat Options Infect Dis       Date:  2020-11-12

Review 3.  Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.

Authors:  Shi-Yuan Wang; Xiao-Hua Cheng; Jing-Xin Li; Xi-Yan Li; Feng-Cai Zhu; Pei Liu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Development of a vaccine to prevent Japanese encephalitis: a brief review.

Authors:  Viroj Wiwanitkit
Journal:  Int J Gen Med       Date:  2009-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.